Abstract
Establishing Safety of a Novel Mesenchymal Stem Cell Therapy to Support a First-in-Human Dose Escalation Study in Steroid-Refractory aGVHD Patients
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have